- Home
- SENEA vs SRDX Comparison
SENEA vs SRDX Comparison
Compare SENEA & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SENEA
- SRDX
- Stock Information
- Founded
- SENEA 1949
- SRDX 1979
- Country
- SENEA United States
- SRDX United States
- Employees
- SENEA N/A
- SRDX N/A
- Industry
- SENEA Packaged Foods
- SRDX Medical/Dental Instruments
- Sector
- SENEA Consumer Staples
- SRDX Health Care
- Exchange
- SENEA Nasdaq
- SRDX Nasdaq
- Market Cap
- SENEA 772.5M
- SRDX 457.0M
- IPO Year
- SENEA N/A
- SRDX 1998
- Fundamental
- Price
- SENEA $107.62
- SRDX $32.37
- Analyst Decision
- SENEA
- SRDX Buy
- Analyst Count
- SENEA 0
- SRDX 3
- Target Price
- SENEA N/A
- SRDX $43.00
- AVG Volume (30 Days)
- SENEA 48.3K
- SRDX 264.6K
- Earning Date
- SENEA 11-05-2025
- SRDX 11-05-2025
- Dividend Yield
- SENEA N/A
- SRDX N/A
- EPS Growth
- SENEA N/A
- SRDX N/A
- EPS
- SENEA 6.24
- SRDX N/A
- Revenue
- SENEA $1,571,618,000.00
- SRDX $120,801,000.00
- Revenue This Year
- SENEA N/A
- SRDX N/A
- Revenue Next Year
- SENEA N/A
- SRDX $3.38
- P/E Ratio
- SENEA $17.55
- SRDX N/A
- Revenue Growth
- SENEA 7.30
- SRDX N/A
- 52 Week Low
- SENEA $60.24
- SRDX $26.00
- 52 Week High
- SENEA $115.40
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- SENEA 46.52
- SRDX 38.89
- Support Level
- SENEA $108.34
- SRDX $31.34
- Resistance Level
- SENEA $111.68
- SRDX $33.17
- Average True Range (ATR)
- SENEA 2.62
- SRDX 0.93
- MACD
- SENEA -0.64
- SRDX -0.34
- Stochastic Oscillator
- SENEA 16.02
- SRDX 22.44
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.